Sarah Warren

Senior Director, Research Technology and Business Development Planning, Kite Pharma

Dr. Sarah Warren is an immunologist, translational scientist, biotech leader, and entrepreneur based in Seattle, WA. She joined Kite Pharma in 2022 as the Senior Director of Research Technology and Business Development Planning where she focuses on identifying novel technologies to address the pressing and emerging needs of cell therapy. Prior to joining Kite, she spent 6 years at NanoString Technologies leading the Translational Science program where she applied multiplexed, molecular profiling technologies to research and diagnostic projects spanning oncology, immunology, and beyond. She was also a founder and Director of Research at Oncofactor Corp, a biotechnology company focused on developing biological therapeutics which targeted novel immune checkpoints. She is active in the immuno-oncology research community to promote the science and application of cancer immunotherapy to improve patient outcomes and has published more than 60 papers and holds 3 patents. She has a PhD in immunology from the University of Washington and performed her graduate work at the Institute for Systems Biology. During graduate school, she was a fellow at the Accelerator Corporation where she supported venture diligence and company creation. Her undergraduate training was at Iowa State University where she graduated with honors in biochemistry and English. She is passionate about improving healthcare for all people.